Emria is a data-backed drug development and care delivery company.
Emyria has raised $2.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2023.
Emyria's investors include Tattarang, Tenmile, 62 Capital, Taylor Collison Ltd.
Emyria is headquartered in Perth, Australia.
Emria is a data-backed drug development and care delivery company.
Emyria is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Emyria — Funding & Investors." VCBacked, May 1, 2023, https://www.vcbacked.co/company/emyria. Accessed August 14, 2026.
VCBacked. (2023). Emyria — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/emyria
{{cite web |title=Emyria — Funding & Investors |url=https://www.vcbacked.co/company/emyria |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated